CANF Latest Press Releases

-- January 20, 2026 --

Can-Fite Completes Patient Enrollment in Phase 2a Pancreatic Cancer Study of Namodenoson Globe Newswire 7:00 AM

-- December 26, 2025 --

Can-Fite Granted Brazilian Patent for Treatment of Sexual Dysfunction Globe Newswire 7:00 AM

-- December 23, 2025 --

Can-Fite Announces Reverse Split of its Ordinary Shares and ADS Ratio Change Globe Newswire 4:46 PM

-- December 16, 2025 --

Can-Fite Provides Update on Clinical and Financial Status Globe Newswire 9:19 AM

-- November 26, 2025 --

Can-Fite's Latest Developments of its Advanced Stage Drug Pipeline will be Presented at Noble Capital Markets 21st Annual Emerging Growth Equity Conference Globe Newswire 7:00 AM

-- November 24, 2025 --

Can-Fite to Advance New Veterinary Partnership Opportunities for Namodenoson at the BioFIT 2025 Conference Globe Newswire 7:00 AM

-- November 20, 2025 --

Can-Fite's CF602 Erectile Dysfunction Treatment Receives Notice of Patent Allowance in Brazil Globe Newswire 7:00 AM

-- November 18, 2025 --

Can-Fite: 9-Year Survival with Complete Cure in an Advanced Liver Cancer Patient Treated with Namodenoson Globe Newswire 7:00 AM

-- September 15, 2025 --

Can-Fite Reports Complete Resolution of Esophageal Varices in Decompensated Cirrhosis Patient Treated with Namodenoson Globe Newswire 7:00 AM

-- August 28, 2025 --

Can-Fite Reports H1 2025 Financial Results and Clinical Update Globe Newswire 8:47 AM

Market Data Delayed 15 Minutes

Questions? Feedback?Olark live chat software